AstraZeneca Covid-19 vaccine not perfect, but saves lives, says Chief Executive Soriot Ruchika Sharma13 Feb 2021 4:45 AM GMTNew Delhi: AstraZeneca's Covid-19 vaccine is not perfect, but will have a big impact on the pandemic, its chief executive predicted on Thursday, as...
AstraZeneca still aiming for Oxford COVID vaccine by 2020 end, says CEO Ruchika Sharma11 Sep 2020 7:34 AM GMTThe trial was halted after a person in the UK who was participating in it got sick, triggering a review of safety data.
AstraZeneca receives 1 Billion USD investment for Oxford vaccine MD Bureau22 May 2020 5:15 AM GMTThe deal includes a Phase III clinical trial with 30,000 participants and a paediatric trial.
AstraZeneca buys ZS Pharma for $2.7 billion, pips Actelion Pooja Bhatia Bhatia7 Nov 2015 3:30 AM GMTLondon: Britain's AstraZeneca has said that it had agreed to buy U.S biotech company ZS Pharma for $2.7 billion, pipping Swiss firm Actelion to...
